Sunday, Nov 22, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Bharat Biotechs Covaxin To Boost Immune Response With Virovax Adjuvant

Bharat Biotech’s Covaxin to boost immune response with ViroVax adjuvant  

Hyderabad-headquartered company is currently conducting Phase II human trials of Covaxin after receiving Drug Controller General of India nod

By Y V Phani Raj
Published Date - 5 October 2020, 12:38 PM
Bharat Biotech’s Covaxin to boost immune response with ViroVax adjuvant  
Dr.Krishna M Ella CMD BBIL
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based vaccines manufacturer Bharat Biotech has announced its novel Coronavirus vaccine Covaxin approved for human trials, will use adjuvant Alhydroxiquim-II to boost immune response and longer lasting immunity. The technology is being used under this licensing agreement with Kansas-based ViroVax.

According to Centers for Disease Control and Prevention, an adjuvant is an ingredient used in some vaccines that helps create a stronger immune response in people receiving the vaccine. In other words, adjuvants help vaccines work better.


Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated at the National Institute of Virology (NIV), Pune, an Indian virology research institute. The inactivated virus is formulated with ViroVax’s adjuvant to produce the vaccine candidate.

Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India (DCGI).

Dr Krishna Ella, CMD of Bharat Biotech, said, “There is a critical need for development and availability of adjuvants that elucidate mechanisms of action inducing greater antibody responses to vaccine antigens, thus resulting in long-term protection against pathogens.”

Adjuvants also enhance the sustainability of the global vaccine supply on account of their antigen-sparing effect.

Dr Ella further added, “The widely used adjuvant Aluminium hydroxide in the development of SARS CoV-2 vaccines is known to induce a Th2 based response (used for eradication of extracellular parasites and bacterial infection). The Th2 based response has a theoretical risk of vaccine associated enhanced respiratory diseases. We have used Imidazoquinoline class of adjuvants (TLR7/8 agonists), which are known to induce Th1 based response which further reduces the risk of ADE (Anti-Body Dependent Enhancement).”

In our pre-clinical studies and animal challenge models (Syrian Hamster and Rhesus Macaques) we have shown that Covaxin induced Th1 based response due to the use of Algel-IMDG (chemisorbed imidazoquinoline onto the aluminium hydroxide gel) as an adjuvant.

In response to the Covid-19 pandemic, ViroVax also received supplemental funding for the development of subunit vaccine constructs for the prevention of Covid-19, and for the discovery and development of therapeutics for treating Covid-19.

ViroVax is evaluating a subunit vaccine candidate and has identified potential antiviral therapeutics. It is currently in the process of testing the efficacy of these compounds.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • adjuvant Alhydroxiquim-II
  • animal challenge models
  • antibody
  • Approval

Related News

  • Hyderabad: Two youths killed as motorcycle crashes into electricity pole at Uppal

    Hyderabad: Two youths killed as motorcycle crashes into electricity pole at Uppal

  • Woman dies by suicide in Hyderabad after mother reprimands her over phone use

    Woman dies by suicide in Hyderabad after mother reprimands her over phone use

  • Loknath Naik’s 104 powers Hyderabad to police T20 title

    Loknath Naik’s 104 powers Hyderabad to police T20 title

  • Kamran Ali century helps Uttar Pradesh take 364-run lead over Hyderabad

    Kamran Ali century helps Uttar Pradesh take 364-run lead over Hyderabad

Latest News

  • Nearly 800 children take part in Hyderabad Kids Run 2026

    12 minutes ago
  • Hyderabad: Krishna Kanth Park visitors seek sanitation fixes, better facilities during HYDRAA chief’s visit

    14 minutes ago
  • TGSRTC saves Rs 36 crore in diesel costs using i-ALERT technology in 1,500 buses

    14 minutes ago
  • D S Narendra Kumar to captain SBI Hyderabad Circle team at inter-SBI volleyball championship

    8 minutes ago
  • Shanmukha Sai Srivatsav, Muddala Kumudha win Under-8 titles at Telangana chess championship

    9 minutes ago
  • Adnan Sami shares unseen childhood picture, urges fans to stay focused on their dreams

    1 hour ago
  • India, Bulgaria exchange five-year roadmap to strengthen bilateral partnership

    1 hour ago
  • Pawan Kalyan orders probe into Jana Sena activist’s death during nomination scrutiny in Kadapa

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App